Bizily Scott 的 Form 4 申報
4D Molecular Therapeutics, Inc.（FDMT），2022/12/5 申報
- 申報編號
- 0001567619-22-021291
- 申報時間
- 2022/12/5
- 交易日
- 2022/12/1
- 申報延遲
- 4 天
- 10b5-1 計畫
- 表單沒有這欄（2023 年以前）
這份申報列了 11 筆非衍生性交易、2 筆衍生性交易。公開市場賣出合計 $13.7 萬。交易後 4 天申報。
申報人
一份 Form 4 可以有好幾位申報人，例如本人與他控制的基金。各交易表上顯示的是第一位。
| 申報人 | 與公司的關係 |
|---|---|
| Bizily ScottCIK 0001920738 | 高階主管（Chief Legal and HR Officer） |
非衍生性證券（表 I）
普通股等股票的取得與處分，每一列是申報上的一筆。
| 交易日 | 證券 | 交易 | 股數 | 價格 | 金額 | 交易後持股 | 持有方式 | 旗標 |
|---|---|---|---|---|---|---|---|---|
| 2022/12/1 | Common Stock | M行使選擇權取得 | +1,875 | $6.49 | +$12,168.75 | 4,732 | 直接 | |
| 2022/12/1 | Common Stock | S賣出處分 | −400 | $21.52F2 | −$8,608 | 4,332 | 直接 | |
| 2022/12/1 | Common Stock | S賣出處分 | −975 | $22.71F3 | −$22,142.25 | 3,357 | 直接 | |
| 2022/12/1 | Common Stock | S賣出處分 | −400 | $23.25F4 | −$9,300 | 2,957 | 直接 | |
| 2022/12/1 | Common Stock | S賣出處分 | −100 | $24.49 | −$2,449 | 2,857 | 直接 | |
| 2022/12/1 | Common Stock | M行使選擇權取得 | +3,750 | $8.04 | +$30,150 | 6,607 | 直接 | |
| 2022/12/1 | Common Stock | S賣出處分 | −1,000 | $21.78F5 | −$21,780 | 5,607 | 直接 | |
| 2022/12/1 | Common Stock | S賣出處分 | −2,450 | $22.93F6 | −$56,178.5 | 3,157 | 直接 | |
| 2022/12/1 | Common Stock | S賣出處分 | −200 | $23.44 | −$4,688 | 2,957 | 直接 | |
| 2022/12/1 | Common Stock | S賣出處分 | −100 | $24.49 | −$2,449 | 2,857 | 直接 | |
| 2022/12/1 | Common Stock | S賣出處分 | −375 | $24.35 | −$9,131.25 | 2,482 | 直接 |
衍生性證券（表 II）
選擇權、認股權證、限制型股票單位等。股數是標的股票的股數；單價與金額是衍生證券本身的價格，交易後持有是衍生證券的單位數。
| 交易日 | 證券 | 交易 | 標的股數 | 單價 | 金額 | 交易後持有 | 持有方式 | 旗標 |
|---|---|---|---|---|---|---|---|---|
| 2022/12/1 | Common Stock | M行使選擇權處分 | −1,875 | $0.00 | $0 | 22,125 | 直接 | |
| 2022/12/1 | Common Stock | M行使選擇權處分 | −3,750 | $0.00 | $0 | 56,250 | 直接 |
附註與備註
本站收錄交易價格引用的附註、修正申報（Form 4/A）的全部附註，以及申報的備註。其他附註，例如間接持有的方式、交易計畫的細節，請看 SEC EDGAR 上的原文。
- F2
The transaction was executed in multiple trades in prices ranging from $20.92 to $21.79, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
表 I 有 1 筆交易的價格引用這則附註。
- F3
The transaction was executed in multiple trades in prices ranging from $22.13 to $23.11, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
表 I 有 1 筆交易的價格引用這則附註。
- F4
The transaction was executed in multiple trades in prices ranging from $23.16 to $23.38, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
表 I 有 1 筆交易的價格引用這則附註。
- F5
The transaction was executed in multiple trades in prices ranging from $21.21 to $22.12, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
表 I 有 1 筆交易的價格引用這則附註。
- F6
The transaction was executed in multiple trades in prices ranging from $22.39 to $23.36, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
表 I 有 1 筆交易的價格引用這則附註。